Labetalol

Chemical formula: C₁₉H₂₄N₂O₃  Molecular mass: 328.406 g/mol  PubChem compound: 3869

Therapeutic indications

Labetalol is indicated for:

Indication

Population group: only adults (18 years old or older)

at least one of
Hypertension
Hypertension secondary to endocrine disorders and additionally Phaeochromocytoma

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: women, only adults (18 - 65 years old)

at least one of
Gestational [pregnancy-induced] hypertension without significant proteinuria
Pre-eclampsia
Eclampsia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: LABELATOL Solution for injection
Summary of Product Characteristics (SPC) 2019: TRANDATE Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈